483 KBI Biopharma Mar 2020

483 KBI Biopharma Mar 2020

Erika Butler FDA, Genoula Ryan FDA$119.00 - Available Now

FDA investigators audited the KBI Biopharma - Boulder, CO, United States facility and issued inspectional observations (via FDA 483) on 06 Mar 2020.

Product details

  • Category: Human Drugs
  • Inspection end: 06 Mar 2020
  • Location: Boulder, United States
  • FEI: 3011326133
Add To Cart